Saqib Islam Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Saqib Islam is Chief Executive Officer of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 1.01 Million shares of SWTX, which is worth approximately $36.1 Million. The most recent transaction as insider was on Dec 02, 2024, when has been sold 49,000 shares (Common Stock) at a price of $41.59 per share, resulting in proceeds of $2,037,910. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.01M

4.61% 3M change

409.6% 12M change

Total Value Held $36.1 Million

Saqib Islam Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Open market or private sale	$2,037,910 $41.59 p/Share	49,000 Reduced 4.61%	1,014,368 Common Stock
Sep 03 2024	SELL Open market or private sale	$2,013,410 $41.09 p/Share	49,000 Reduced 4.41%	1,063,368 Common Stock
Jun 03 2024	SELL Open market or private sale	$2,002,629 $40.87 p/Share	49,000 Reduced 4.22%	1,112,368 Common Stock
Jan 08 2024	SELL Payment of exercise price or tax liability	$743,553 $41.53 p/Share	17,904 Reduced 6.53%	256,264 Common Stock
Jan 05 2024	SELL Payment of exercise price or tax liability	$489,114 $37.96 p/Share	12,885 Reduced 4.49%	274,168 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	88,000 Added 23.46%	287,053 Common Stock
Nov 30 2023	BUY Grant, award, or other acquisition	-	199,053 Added 50.0%	199,053 Common Stock
Jan 07 2023	SELL Payment of exercise price or tax liability	$108,201 $26.41 p/Share	4,097 Reduced 0.45%	905,104 Common Stock
Jan 06 2023	SELL Payment of exercise price or tax liability	$231,168 $27.52 p/Share	8,400 Reduced 0.92%	909,201 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	84,175 Added 8.4%	917,601 Common Stock
Jan 07 2022	SELL Payment of exercise price or tax liability	$330,362 $56.06 p/Share	5,893 Reduced 0.69%	851,695 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	78,370 Added 8.37%	857,588 Common Stock
Oct 20 2021	SELL Open market or private sale	$591,570 $58.67 p/Share	10,083 Reduced 1.28%	779,218 Common Stock
Oct 19 2021	SELL Open market or private sale	$827,868 $58.81 p/Share	14,077 Reduced 1.8%	769,135 Common Stock
Oct 18 2021	SELL Open market or private sale	$2,246,341 $58.59 p/Share	38,340 Reduced 4.67%	783,212 Common Stock
Jul 20 2021	SELL Open market or private sale	$1,442,673 $77.68 p/Share	18,572 Reduced 2.21%	821,552 Common Stock
Jul 19 2021	SELL Open market or private sale	$3,342,481 $76.09 p/Share	43,928 Reduced 4.97%	840,124 Common Stock
Apr 20 2021	SELL Open market or private sale	$1,598,339 $66.39 p/Share	24,075 Reduced 2.65%	884,052 Common Stock
Apr 19 2021	SELL Open market or private sale	$2,652,862 $69.04 p/Share	38,425 Reduced 4.06%	908,127 Common Stock
Jan 20 2021	SELL Open market or private sale	$173,171 $78.75 p/Share	2,199 Reduced 0.18%	1,222,997 Common Stock
Jan 19 2021	SELL Open market or private sale	$4,736,041 $78.54 p/Share	60,301 Reduced 4.69%	1,225,196 Common Stock
Jan 07 2021	BUY Grant, award, or other acquisition	-	37,500 Added 2.83%	1,285,497 Common Stock

Also insider at

SBTX

Silverback Therapeutics, Inc. Healthcare

PASG

Passage BIO, Inc. Healthcare

Saqib Islam

Chief Executive Officer

Stamford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX

Account